Australian court supports patents on human genes
CANBERRA (Reuters) – An Australian court ruled on Friday that two technology companies could hold a patent on genetic material related to cancer, in a case similar to one before the U. S. Supreme Court that has implications for gene-based medicine worldwide. Cancer support groups said the finding could stifle new breast cancer research and treatment. Australia’s Federal Court ruled that U. S. company Myriad Genetics Inc and Melbourne-based Genetic Technologies Ltd had the right to hold a patent on human genetic material. . . .
View full post on Health News Headlines – Yahoo! News
Leave a Reply